Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia

Neurological Research

Volumn 30, Issue 3, 2008, Pages 288-293

  Chi, Oak Za ^a   Hunter, Christine ^a   Liu, Xia ^a   Weiss, Harvey R ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Blood brain barrier; Deferoxamine; Focal cerebral ischemia; VEGF

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; DEFEROXAMINE MESYLATE; DEXTRAN; SODIUM CHLORIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; RAT; STATISTICAL SIGNIFICANCE;

AMINOISOBUTYRIC ACIDS; ANIMALS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; DEFEROXAMINE; DEXTRANS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMICS; ISOTOPES; MALE; RATS; RATS, WISTAR; SIDEROPHORES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 44449108066     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X230135     Document Type: Article

References (39)

1. Pichiule P, Agani F, Chaves JC, et al. HIF-1 alpha and VEGF expression after transient global cerebral ischemia. Adv Exp Med Biol 2003; 530: 611-617
2. Semenza GL. Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology 2004; 19: 176-182
3. Jones NM, Bergeron M. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J Cereb Blood Flow Metab 2001; 21: 1105-1014
4. Bernaudin M, Nedelec AS, Divoux D, et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF in the adult mouse brain. J Cereb Blood Flow Metab 2002; 22: 393-403
5. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995; 370: 203-208
6. Fischer S, Wobben M, Marti HH, et al. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 2002; 63: 70-80
7. Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-838
8. Zhang ZG, Zhang L, Tsang W, et al. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 2002; 22: 379-392
9. Wang RG, Zhu XZ. Expression of angiopoietin-2 and vascular endothelial growth factor in mice cerebral cortex after permanent focal cerebral ischemia. Acta Pharmacol Sin 2002; 23: 405-411
10. Prass K, Ruscher K, Karsch M, et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 2002; 22: 520-525
11. Pham I, Uchida T, Planes C, et al. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1133-L1142
12. Gross PM, Blasberg RG, Fenstermacher JD, et al. The microcirculation of rat circumventricular organs and pituitary gland. Brain Res Bull 1987; 18: 73-85
13. Albayrak S, Zhao O, Siesjo BK, et al. Effect of transient focal ischemia on blood-brain barrier permeability in the rat: Correlation to cell injury. Acta Neuropathol (Berl) 1997; 94: 158-163
14. Chi OZ, Liu X, Weiss HR. Effects of 17beta-estradiol on blood-brain barrier disruption during focal ischemia in rats. Horm Metab Res 2002; 34: 530-534
15. Chi OZ, Hunter C, Liu X, et al. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex. Neurol Res 2005; 27: 864-868
16. Bergeron M, Gidday JM, Yu AY, et al. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000; 48: 285-296
17. Croll SD, Wiegand SJ. Vascular growth factor in cerebral ischemia. Mol Neurobiol 2001; 23: 121-135
18. Zhang Z, Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 2002; 12: 62-66
19. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke 1998; 29: 705-718
20. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997; 20: 132-139
21. Chi OZ, Wei HM, Sinha AK, et al. Effects of inhibition of nitric oxide synthase on blood-brain barrier transport in focal cerebral ischemia. Pharmacology 1994; 48: 367-373
22. Chi OZ, Chang Q, Weiss HR. Effects of topical N-methyl-D-aspartate on blood-brain barrier permeability in the cerebral cortex of normotensive and hypertensive rats. Neurol Res 1997; 19: 539-544
23. Leker RR, Teichner A, Ovadia H, et al. Expression of endothelial nitric oxide synthase in the ischemic penumbra: Relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor. Brain Res 2001; 909: 1-7
24. Ikeda E, Achen M, Brier G, et al. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995; 270: 19761-19766
25. Gelinas DS, Bernatchez PN, Rollin S, et al. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: Role of PI3K, PKC and PLC pathways. Br J Pharmacol 2002; 137: 1021-1030
26. Mayhan WG. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol Cell Physiol 1999; 276: C1148-C1153
27. 121- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol 2001; 280: H1097-H1104
28. Wu HM, Huang Z, Yuan Y, et al. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol Heart Circ Physiol 1996; 271: H2735-H2739
29. Murohara T, Horowitz JR, Silver M, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998; 97: 99-107
30. Sirois MD, Edelman ER. VEGF effect on vascular permeability is mediated by synthesis of platelet activating factor. Am J Physiol Heart Circ Physiol 1997; 272: H2746-H2756
31. 2+-dependent pathway. Am J Physiol Heart Circ Physiol 1997; 273: H687-H694
32. Hippenstiel S, Krull M, Ikemann A, et al. VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol Lung Cell Mol Physiol 1998; 274: L678-L684
33. Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 2001; 280: H434-H440
34. Breslin JW, Pappas PJ, Cerveira JJ, et al. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 2003; 284: H92-H100
35. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994; 89: 2183-2189
36. Han MK, Kim M, Bae SY, et al. VEGF protects human cerebral hybrid neurons from in vitro ischemia. Neuroreport 2004; 15: 847-850
37. Matsuzaki H, Tamatani M, Yamaguchi A, et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: Signal transduction cascades. FASEB J 2001; 15: 1218-1220
38. Svensson B, Peters M, Konig HG, et al. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J Cereb Blood Flow Metab 2002; 22: 1170-1175
39. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat 2002; 200: 575-580